Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 15 studies | 35% ± 10% | |
lung | 13 studies | 27% ± 8% | |
brain | 7 studies | 28% ± 13% | |
eye | 7 studies | 31% ± 11% | |
intestine | 6 studies | 23% ± 8% | |
lymph node | 5 studies | 25% ± 4% | |
liver | 5 studies | 29% ± 10% | |
kidney | 4 studies | 29% ± 5% | |
uterus | 4 studies | 37% ± 8% | |
breast | 4 studies | 29% ± 5% | |
bone marrow | 3 studies | 26% ± 9% | |
prostate | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2722.07 | 180 / 180 | 100% | 172.65 | 430 / 430 |
brain | 100% | 6861.87 | 2631 / 2642 | 99% | 116.67 | 701 / 705 |
adrenal gland | 100% | 2957.06 | 258 / 258 | 98% | 119.81 | 226 / 230 |
esophagus | 98% | 2785.59 | 1411 / 1445 | 100% | 109.50 | 183 / 183 |
skin | 99% | 3508.79 | 1786 / 1809 | 97% | 90.48 | 459 / 472 |
uterus | 100% | 2889.51 | 170 / 170 | 95% | 78.48 | 435 / 459 |
thymus | 96% | 2279.59 | 627 / 653 | 98% | 110.39 | 594 / 605 |
prostate | 98% | 2668.07 | 240 / 245 | 95% | 73.82 | 477 / 502 |
bladder | 95% | 3309.38 | 20 / 21 | 97% | 98.39 | 489 / 504 |
lung | 99% | 3590.57 | 572 / 578 | 92% | 56.72 | 1060 / 1155 |
intestine | 93% | 2277.72 | 899 / 966 | 97% | 119.89 | 512 / 527 |
stomach | 87% | 1738.30 | 312 / 359 | 98% | 115.17 | 280 / 286 |
breast | 99% | 2889.90 | 456 / 459 | 81% | 51.39 | 903 / 1118 |
kidney | 90% | 1544.72 | 80 / 89 | 86% | 54.76 | 775 / 901 |
pancreas | 67% | 791.89 | 221 / 328 | 90% | 78.25 | 160 / 178 |
liver | 58% | 623.44 | 132 / 226 | 82% | 37.86 | 334 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 175.93 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 200.36 | 29 / 29 |
spleen | 100% | 3808.65 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 59.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 264.90 | 1 / 1 |
adipose | 99% | 3476.53 | 1189 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 3526.30 | 1314 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 3203.76 | 844 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 1708.26 | 732 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 1873.02 | 762 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0030154 | Biological process | cell differentiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005813 | Cellular component | centrosome |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070097 | Molecular function | delta-catenin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CCDC85B |
Protein name | Coiled-coil domain-containing protein 85B (Hepatitis delta antigen-interacting protein A) (Delta-interacting protein A) |
Synonyms | DIPA |
Description | FUNCTION: Functions as a transcriptional repressor . May inhibit the activity of CTNNB1 in a TP53-dependent manner and thus regulate cell growth . May function in adipocyte differentiation, negatively regulating mitotic clonal expansion (By similarity). Plays a role in cell-cell adhesion and epithelium development through its interaction with proteins of the beta-catenin family (By similarity). .; FUNCTION: (Microbial infection) Plays a role in hepatitis delta virus (HDV) genomic replication. . |
Accessions | ENST00000312579.4 Q15834 |